Sustained-release diclofenac potassium orally disintegrating tablet incorporating eudragit ERL/ERS: possibility of specific diclofenac-polymer interaction

Aly AM, Semreen M, Qato MK (2005) Superdisintegrants for solid dispersion to produce rapidly disintegrating tenoxicam tablets via camphor sublimation. Pharm Technol 29:68–78 Andrews G, Jones D (2006) In: Rowe RC, Sheskey PJ, Owen SC (eds), Handbook of pharmaceutical excipients, 5th edn. Pharmaceutical Press, Great Britain and American Pharmacists Association, Washington, DC Assaf S, Qandil A, Al-Ani E (2013) Fast and pH-dependent release of domperidone from orally disintegrating tablets. Pharm Dev Technol 18(04):897–905. doi:10.3109/10837450.2011.583925 Athamneh N, Tashtoush B, Qandil A, Al-Taani B, Obaidat A, Al-Jbour N, Qinna N, Al-Sou’od K, Al Remawi M, Badwan A (2013) A new controlled release liquid delivery system based on diclofenac potassium and low molecular weight chitosan complex solubilized in polysorbates. Drug Dev Ind Pharm 39(08):1217–1229. doi:10.3109/03639045.2012.707205 Blanco-Prı′eto MaJ, Campanero MA, Besseghir K, Heimgatner F, Gander B (2004) Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. J Controlled Release 96:437–448 Bodmeier R, Dong W (2006) Encapsulation of lipophilic drugs within enteric microparticles by a novel coacervation method. Int J Pharm 326:128–138 Burke A, Smyth E, FitzGerald GA (2006) In: Brunton LL, Lazo JS, Parker KL (eds), Goodman & Gilman’s the pharmacological basis of therapeutics. McGrawHill, New York Center for Drug Evaluation and Research (CDER) (1997) SUPAC-MR: modified release solid oral dosage forms. Food and Drug Administration, Rockville Chourasia MK, Jain SK (2003) Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci 6(1):33–66 Chuasuwan B, Binjesoh V, Polli JE, Zhang H, Amidon GL, Junginger HE, Midha KK, Shah VP, Stavchansky S, Dressman JB, Barends DM (2009) Biowaiver monographs for immediate release solid oral dosage forms: diclofenac sodium and diclofenac potassium. J Pharm Sci 98(4):1206–1219 Clarke A, Brewer F, Johnson E, Mallard N, Hartig F, Taylor S, Corn T (2003) A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition. J Neura Transm 110(11):1273–1278 Corveleyn S, Remon JP (1998) Bioavailability of hydrochlorothiazide: conventional versus freeze-dried tablets. Int J Pharm 173:149–155 Council of Europe (2002) European pharmacopoeia. Council of Europe Dobetti L (2001) Fast-Melting tablets: developments and technologies. Pharmaceutical Technology, pp 44–50 Fini A, Garuti M, Fazio G, Alvarez-Fuentes J, Holgado MA (2001) Diclofenac salts. I. Fractal and thermal analysis of sodium and potassium diclofenac salts. J Pharm Sci 90(12):2049–2057. doi:10.1002/jps.1156 Fini A, Cavallari C, Ospitali F (2010) Diclofenac salts. V. Examples of Polymorphism among diclofenac salts with alkyl-hydroxy amines studied by DSC and HSM. Pharmaceutics 2:136–158. doi:10.3390/pharmaceutics2020136 Food and Drug Administration (2008) Guidance for the industry; orally disintegartiing tablets. Center for Drug Evaluation and Research (CDER) Ghosh TK, Pfister WR (2005) Orally disintegrating tablets, products, technologies, and development. Pharm Technol 29(10):136–151 Ichikawa H, Fujioka K, Adeyeye MC, Fukumori Y (2001) Use of ion-exchange resins to prepare 100 μm-sized microcapsules with prolonged drug-release by the Wurster process. Int J Pharm 216:67–76 Kenji S, Mayuko I, Noriko M, Mizue M, Daisuke K, Masatoshi Y, Naoko I, Hiroyuki I, Masayuki K (2000) Utility of prescription information to screen drug candidates suitable for orally disintegrating tablets. J Pharm Sci Technol, Jpn 60(2):166–174 Kılıçarslan M, Baykara T (2003) The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. Int J Pharm 252:99–109 Kristjansson TE (2008) Rapidly disintegrating dosage form comprising magnesium carbonate heavy. USA Patent Li M, Rouaud O, Poncelet D (2008) Microencapsulation by solvent evaporation: state of the art for processengineering approaches. Int J Pharm 363:26–39 Lin Y, Alexandridis Paschalis (2000) Physicochemical aspects of drug delivery and release from polymer-based colloids. Curr Opin Colloid Interface Sci 5(1–2):132–143 Lu B, Wen R, Yang H, Hea Y (2007) Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization. Int J Pharm 333:87–94 Mateovic T, Kriznar B, Bogataj M, Mrhar A (2002) The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres. J Micrencapsul 19(1):29–36 Matovic-Rojnik T, Frlan R, Bogataj M, Bukovec P, Mrhar A (2005) Effect of preparation temperature in solvent evaporation process on Eudragit RS microsphere properties. Chem Pharm Bull 53(1):143–146 Mizumoto T, Masuda Y, Yamamoto T, Yonemochi E, Terada K (2005) Formulation design of a novel fast-disintegrating tablet. Int J Pharm 306:83–90 Oliveira WP, Rattes ALR (2004) Spray drying as a method for microparticulate modified release systems preparation. B:1112–1119 Reverchon E, Lamberti G, Antonacci A (2008) Supercritical fluid assisted production of HPMC composite microparticles. J Supercrit Fluids 46:185–196 Shah SU, Khan GM, Jan SU, Shah KU, Hussain A, Khan H, Khan KA (2012) Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates. Pak J Pharm Sci 25(1):161–168 Shimizu T, Nakano Y, Morimoto S, Tabata T, Hamaguchi N, Igari Y (2003) Formulation study for lansoprazole fast-disintegrating tablet. I. Effect of compression on dissolution behavior. Chem Pharm Bull 51(8):942–947 Shu T, Suzuki H, Hironaka K, Ito K (2002) Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone. Chem Pharm Bull 50(2):193–198 Singh H, Gupta VK, Mittal A, Sharma S (2007) Improved stabilization of microencapsulated Cathepsin B in harsh conditions. Enzyme Microb Technol 40:337–342 Sugimoto M, Maejima T, Narisawa S, Matsubara K, Yoshino H (2005) Factors affecting the characteristics of rapidly disintegrating tablets in the mouth prepared by the crystalline transition of amorphous sucrose. Int J Pharm 296:64–72 Sunada H, Bi Y (2002) Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol 122(2):188–198. doi:10.1016/S0032-5910(01)00415-6 Xu J, Bovet LL, Zhao K (2008) Taste masking microspheres for orally disintegrating tablets. Int J Pharm 359:63–69